EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Decreased risk of nosocomial transmission of hepatitis B and C viruses among hemodialysis patients in Southern Bulgaria

Radka T Komitova, Elitsa N Golkocheva-Markova, Ani K Kevorkyan, Lubomira Nikolaeva-Glomb, Vanya R Rangelova, Tanya I Kostadinova, Tsvetelina Chardakova, Mariya V Atanasova, Tencho D Tenev, George S Kiprin, Simon K Sariyan, Ralitsa D Raycheva und 1 weitere

The Journal of Infection in Developing Countries · 2025

DOI: 10.3855/jidc.20035 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Infection in Developing Countries, 2025. Verfasst von Radka T Komitova und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Parasitology and Tropical Medicine, Faculty of Medicine, Medical University of Plovdiv, Plovdiv, Bulgaria. Hauptthemen laut MEDLINE: Renal Dialysis, Hepatitis B, Cross Infection, Hepatitis C. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Hepatitis B (HBV) and (HCV) virus infections represent a nosocomial risk in hemodialysis (HD) patients. We aimed to evaluate the risk among adult HD patients in southern Bulgaria. Methodology: A prospective cohort study included 225 patients from three HD centers between January 2020 and June 2022. HBV and HCV infections were characterized by serological and virological markers determined through enzyme-linked immunosorbent assay and polymerase chain reaction.

Results

HBV infection was detected in 13 patients and HCV in 15. Ten of the hepatitis patients died of non-liver-related complications. Sustained virological response (SVR) was confirmed in five HCV-infected patients previously cured with direct-acting antivirals (DAAs). Five patients were viremic. Three of them achieved SVR after DAAs, and two refused treatments. A decrease in HCV viremia prevalence (2.22% versus 0.89%) was recorded (p = 0.15). Virological suppression was confirmed in four HBV-infected patients treated with nucleos(t)ide analogs. Тwo patients were not eligible for antivirals. Decreased HBV viremia prevalence (2.7% versus 0.89%) was recorded (p = 0.15). Among HBV surface antigen (HBsAg)-negative patients, HBV vaccination coverage was 62.74% (133/212) and higher in 2 HD centers (128/137; 93.43%). Nevertheless, one-third of participants (34/112; 30.36%) were susceptible to HBV. Twenty-four vaccinees (24/112; 21.43%) had acquired natural immunity but remained at risk of reactivation in case of immunosuppression. HBV DNA was detected in eight HBsAg-negative patients, resulting in a prevalence of 7.14% (8/112) for occult HBV infection.

Conclusions

The study reveals a downward trend in HBV and HCV viremia prevalence among HD patients. To further reduce the risk of nosocomial transmission, vaccination for hepatitis B requires updating.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Renal DialysisHepatitis BCross InfectionHepatitis CHumansBulgariaMaleFemaleMiddle AgedProspective StudiesAdultAgedPrevalenceAntiviral AgentsViremiaHepatitis B virusHepacivirusRisk Factors

Stichwörter der Autor:innen

Hepatitis BHepatitis Chemodialysisnosocomial transmissionviremia

Substanzen

Antiviral Agents

Autor:innen und Institutionen

  • Department of Infectious Diseases, Parasitology and Tropical Medicine, Faculty of Medicine, Medical University of Plovdiv, Plovdiv, Bulgaria.
  • National Reference Laboratory "Hepatitis Viruses", Department of Virology, National Center of Infectious and parasitic Diseases, Sofia, Bulgaria.
  • Department of Epidemiology and Disaster Medicine, Faculty of Public Health, Medical University of Plovdiv, Plovdiv, Bulgaria.
  • National Reference Laboratory of Enteroviruses, National Center for Infectious and Parasitic Diseases, Sofia, Bulgaria.
  • First Dialysis Services Bulgaria, Plovdiv, Bulgaria.
  • First Dialysis Services Bulgaria, Pazardzhik, Bulgaria.

Zitieren

APA

Komitova, R. T., Golkocheva-Markova, E. N., Kevorkyan, A. K., Nikolaeva-Glomb, L., Rangelova, V. R., Kostadinova, T. I., Chardakova, T., Atanasova, M. V., Tenev, T. D., Kiprin, G. S., Sariyan, S. K., Raycheva, R. D., & Tzekov, V. D. (2025). Decreased risk of nosocomial transmission of hepatitis B and C viruses among hemodialysis patients in Southern Bulgaria. The Journal of Infection in Developing Countries. https://doi.org/10.3855/jidc.20035

Vancouver

Komitova RT, Golkocheva-Markova EN, Kevorkyan AK, Nikolaeva-Glomb L, Rangelova VR, Kostadinova TI, et al. Decreased risk of nosocomial transmission of hepatitis B and C viruses among hemodialysis patients in Southern Bulgaria. The Journal of Infection in Developing Countries. 2025. doi:10.3855/jidc.20035

BibTeX
@article{Komitova2025,
  author = {Komitova, Radka T and Golkocheva-Markova, Elitsa N and Kevorkyan, Ani K and Nikolaeva-Glomb, Lubomira and Rangelova, Vanya R and Kostadinova, Tanya I and Chardakova, Tsvetelina and Atanasova, Mariya V and Tenev, Tencho D and Kiprin, George S and Sariyan, Simon K and Raycheva, Ralitsa D and Tzekov, Valeri D},
  title = {Decreased risk of nosocomial transmission of hepatitis B and C viruses among hemodialysis patients in Southern Bulgaria},
  journal = {The Journal of Infection in Developing Countries},
  year = {2025},
  doi = {10.3855/jidc.20035}
}
Kostenlos starten →